| NCT ID | NCT07846566 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Cleveland Clinic |
| Condition | Dementia (Diagnosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2026-10-09 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2026-10-09 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to see if an educational interactive booklet about how dementia progresses throughout a person's life can be a helpful tool for patients to think about future decisions that might need to be made regarding their medical care and helping patients discuss their diagnosis and possible future medical decisions with their family or future caregivers.
Eligibility Criteria
Inclusion Criteria: * Participants are at least 18 years of age * Patients including those: newly diagnosed (within 30 days of informed consent discussion) and established patients diagnosed with mild cognitive impairment or clinical suspicion of mild Alzheimer's dementia diagnosis based on Montreal Cognitive Assessment score (MoCA): 14+, Mini Mental State Exam (MMSE) score: 21+ or Functional Assessment Staging Toll (FAST) score: 1-4 * Able to read and respond to questions in English (workbook is not available in any other language and survey instruments are validated in English language). Exclusion Criteria: * Individuals who lack decisional capacity * Individuals who possess comorbid conditions that, in the opinion of the investigator, would place unnecessary additional burden upon a patient for study participation or patients for whom participation the study would not be in their best interests.
Contact & Investigator
Kimberlee Fong, DO
PRINCIPAL INVESTIGATOR
The Cleveland Clinic
Frequently Asked Questions
Who can join the NCT07846566 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dementia (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07846566 currently recruiting?
Yes, NCT07846566 is actively recruiting participants. Contact the research team at rennerh2@ccf.org for enrollment information.
Where is the NCT07846566 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT07846566 clinical trial?
NCT07846566 is sponsored by The Cleveland Clinic. The principal investigator is Kimberlee Fong, DO at The Cleveland Clinic. The trial plans to enroll 25 participants.